Objectives : The aim of this study was to investigate the potential role of brain natriuretic
peptide (BNP) levels in the assessment of functional status and right heart performance in …

Rationale: The detection of pulmonary hypertension in patients with chronic lung disease
has prognostic implications. The brain natriuretic peptide (BNP) has been suggested as a …

Pulmonary hypertension (PH) can develop in lung fibrosis, and contributes to increased
morbidity and mortality. Noninvasive parameters in the evaluation of PH in lung disease could …

Background Pirfenidone has been shown to slow disease progression in patients with
idiopathic pulmonary fibrosis (IPF). However, there are few treatment options for progressive …

After introduction of the new international guidelines on idiopathic pulmonary fibrosis (IPF)
in 2011, we investigated clinical management practices for patients with IPF according to …

Pulmonary rehabilitation is recommended for patients with chronic lung diseases including
idiopathic pulmonary fibrosis according to international guidelines. However, data for …

Study objectives Different vasodilators and different routes of application are used for the
treatment of primary pulmonary hypertension (PPH). Recently, sildenafil, a phosphodiesterase-…

The INSIGHTS-IPF registry provides one of the largest data sets of clinical data and self-reported
patient related outcomes including health related quality of life (QoL) on patients with …

Study objectives Pulmonary arterial hypertension (PAH) leads to substantial morbidity and
mortality. Noninvasive parameters in the follow-up assessment of PAH could be helpful in …

Objective There is a paucity of observational data on antifibrotic therapy for idiopathic pulmonary
fibrosis (IPF). We aimed to assess the course of disease of IPF patients with and without …